Recently, The project "Velocity Distribution of Intravascular Optical Coherence Tomography and Research and Development of Key Technology and System for Elastic Imaging" of Tianjin Science and Technology Commission, in which Tianjin University acts as the responsible unit of the project, Tianjin Institute of Cardiology, the enterprise of the free trade zone, Tianjin Hengyu Medical Technology Co., Ltd. (hereinafter referred to as "Hengyu Medical") act as the cooperative units, has successfully completed
　　Since its establishment in 2016, Hengyu Medical has consistently focused on the field of intravascular imaging, and has established core competitive advantages in technologies and products related to OCT (intravascular optical coherence tomography), IVUS (intravascular ultrasound) and intravascular multimodal imaging, gradually built a complete business system including R&D, production and sales, and has clear strategic planning and cutting-edge technical reserves in long-term development. At present, the cardiovascular optical coherence tomography (OCT) system of Hengyu Medical has been registered and accepted, and the clinical trial of intravascular ultrasound (IVUS) has been completed, and the registration application will be made soon.